Skip to main content
. 2018 Mar 22;13(3):e0194653. doi: 10.1371/journal.pone.0194653

Table 1. Socio-demographic and clinical characteristics of all participants and according to gender.

Characteristic Participants (n = 200) Females (n = 140) Males (n = 60) P value
Age in years (mean ± SD) 39.1±9.4 38.4±9.8 40.7±8.3 0.123
Married, n (%) 89 (44.5%) 49 (35%) 40 (66.7%) <0.001
Waist circumference in cm (mean ± SD) 80.3±7.9 80.2±7.9 80.7±7.7 0.660
WC-defined central obesity, prevalence (%) 33.5% 94.0% 6.0% <0.001
Hip circumference in cm (mean ± SD) 94.0±8.0 94.2±8.3 93.6±7.3 0.635
WHR (mean ± SD) 0.86±0.06 0.85±0.06 0.86±0.07 0.277
WHR-defined central obesity, prevalence (%) 44.5% 52.9% 25.0% <0.001
Weight in Kg (mean ± SD) 65.8±9.4 64.2±9.5 69.4±8.4 0.270
Height in meters (mean ± SD) 1.65±0.07 1.63±0.07 1.70±0.06 0.926
WHtR (mean ± SD) 0.49±0.05 0.49±0.05 0.48±0.05 0.024
Elevated WHtR (WHtR > 0.5, prevalence (%)) 36.5% 40.7% 26.7% 0.059
BMI in Kg/m2 (mean ± SD) 24.1±2.9 24.2±3.0 24.0±2.5 0.709
BMI-defined overweight, prevalence (%) 40.5% 44.29% 31.67% 0.096
BMI categories 0.140
Underweight 2 (1.0%) 2 (1.4%) 0 (0.0%)
Normal 117 (58.5%) 76 (54.3%) 41 (68.3%)
Overweight 81 (40.5%) 62 (44.3%) 19 (31.7%)
Obesity 0 (0.0%) 0 (0.0%) 0 (0.0%)
Hypertension (prevalence, %) 28.5% 22.1% 43.3% 0.002
Time since diagnosis of HIV infection in months, median (IQR) 22 (1–68) 18 (1–62) 24 (1–72) 0.860
CD4 cell count in cells/µL, median (IQR) (n = 123) 271 (130–408) 270 (134–409) 274 (80–388) 0.646

BMI–Body Mass Index, CD4—Cluster of differentiation 4, IQR–Interquartile Range, SD–Standard deviation, WC–Waist circumference, WHR–Waist-to-hip ratio, WHtR–Waist-to-height ratio.